Home
About
Overview
Sharing Data
ORCID
Help
History (7)
Interindividual variation contributes to differential PCB 126 induced gene expression in primary breast epithelial cells and tissues.
MAP kinase phosphatase 1 (MKP-1/DUSP1) is neuroprotective in Huntington's disease via additive effects of JNK and p38 inhibition.
Pirfenidone: a novel agent for the treatment of idiopathic pulmonary fibrosis.
Mining endonuclease cleavage determinants in genomic sequence data.
Nintedanib for Idiopathic Pulmonary Fibrosis.
See All 7 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Nintedanib for Idiopathic Pulmonary Fibrosis.
Tepede A, Yogaratnam D. Nintedanib for Idiopathic Pulmonary Fibrosis. J Pharm Pract. 2019 Apr; 32(2):199-206.
View in:
PubMed
subject areas
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Diarrhea
Drug Therapy, Combination
Humans
Idiopathic Pulmonary Fibrosis
Indoles
Protein Kinase Inhibitors
Pyridones
authors with profiles
Dinesh Yogaratnam PharmD